An estimated 4,570 misdiagnoses of prostate cancer occur each year in the U.S., leading to about $880 million in unnecessary medical expenses, due to contamination and switching errors that occur during the biopsy process, according to a new study. The study, “The Clinical and Economic Implications of Specimen Provenance Complications in Diagnostic Prostate Biopsies,” appears …
Continue reading “Study Highlights Consequences of Biopsy Contamination, Switching Errors”
